Ratings
0
Nobody has rated this yet. Be the first!
Works
8
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia
Classification of GBA Variants and Their Effects in Synucleinopathies
Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Precision Medicine for Parkinson's Disease: Ambroxol for Glucocerebrosidase-Associated Parkinson's Disease, First Trial Completed
Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease
Sequencing of the GBA coactivator, Saposin C, in Parkinson disease
Common and rare GCH1 variants are associated with Parkinson's disease
